Mitochondrial Uncoupling Mechanisms in Metabolic Disorders

Mitochondrial uncoupling refers to processes that dissipate the proton motive force across the inner mitochondrial membrane without ATP synthesis, thereby converting energy into heat and altering cellular redox status. In healthy physiology endogenous uncoupling proteins modulate thermogenesis, reactive oxygen species (ROS) production and metabolic flexibility. In metabolic disorders such as obesity, type 2 diabetes and non-alcoholic fatty liver disease, both impaired and excessive coupling contribute to energy imbalance, oxidative stress and insulin resistance. Exogenous uncouplers, including classical protonophores and novel small molecules, offer a means to increase energy expenditure and mitigate lipotoxicity, but their clinical translation faces challenges of tissue selectivity, pharmacokinetics and safety. Genetic and pharmacological investigations have elucidated key roles for uncoupling in adipose thermogenesis, hepatic lipid handling and muscle energy homeostasis, highlighting a dual potential for therapeutic benefit and toxicity. A nuanced understanding of uncoupling mechanisms and selective targeting strategies is essential to harness mitochondrial bioenergetics for the treatment of cardiometabolic disease.

Research from Nature Portfolio

Recent studies have refined the design of mitochondria-directed uncouplers to achieve organ-specific effects. A 2024 investigation demonstrated that conjugation of a lipophilic C8 hydrocarbon chain to classic uncouplers enhanced adipose-tissue accumulation and mitochondrial proton leak in vitro, although rapid metabolic cleavage of the ether linkage limited in vivo efficacy, suggesting the need for more stable bond chemistries for safe adipose targeting. Earlier work characterised a liver-localised uncoupler with favourable oral bioavailability and organ distribution, which in diabetic and steatotic animal models increased hepatic energy expenditure, improved glucose homeostasis independent of insulin, lowered blood pressure and reduced ROS-mediated vascular damage, thereby offering a prototype for tissue-targeted metabolic therapy.

Mitochondrial Uncoupling Mechanisms in Metabolic Disorders publication trend

The graph below shows the total number of articles in mitochondrial uncoupling mechanisms in metabolic disorders across all publications each year (not limited to Nature Index journals).

Technical terms

Mitochondrial uncoupling: The process by which proton back-flow through the inner mitochondrial membrane is dissociated from ATP synthesis, dissipating energy as heat.

Proton gradient: The electrochemical gradient of protons across the inner mitochondrial membrane that drives ATP production in oxidative phosphorylation.

Protonophore: A chemical compound that facilitates proton transport across membranes, collapsing the proton gradient and uncoupling respiration from phosphorylation.

Uncoupling protein (UCP): A member of the mitochondrial carrier family that mediates regulated proton leak, modulating heat production and ROS generation.

Reactive oxygen species (ROS): Chemically reactive molecules formed as by-products of respiration that can damage macromolecules but also act as signalling mediators.

Oxidative phosphorylation (OXPHOS): The process by which the respiratory chain generates a proton gradient to drive ATP synthesis via ATP synthase.

References

1. Mitochondrial uncoupling proteins and energy metabolism. Frontiers in Physiology (2015).
2. Noncoupled Mitochondrial Respiration as Therapeutic Approach for the Treatment of Metabolic Diseases: Focus on Transgenic Animal Models. International Journal of Molecular Sciences (2023).
3. BAM15 as a mitochondrial uncoupler: a promising therapeutic agent for diverse diseases. Frontiers in Endocrinology (2023).
4. Conjugating uncoupler compounds with hydrophobic hydrocarbon chains to achieve adipose tissue selective drug accumulation. Scientific Reports (2024).
5. Antidiabetic and cardiovascular beneficial effects of a liver-localized mitochondrial uncoupler. Nature Communications (2019).
6. Mitochondrial Uncoupling: A Key Controller of Biological Processes in Physiology and Diseases. Cells (2019).